# Phase I, FIH, MTD for MPT0B640, Multi-centre, Open-label, Subject With Locally Advanced or Metastatic Solid Malignancies

> **NCT04294875** · EARLY_PHASE1 · WITHDRAWN · sponsor: **J Ints Bio**

## Conditions studied

- Advanced Solid Tumor
- Metastatic Solid Tumor

## Interventions

- **DRUG:** MPT0B640

## Key facts

- **NCT ID:** NCT04294875
- **Lead sponsor:** J Ints Bio
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-12
- **Primary completion:** 2027-11
- **Final completion:** 2027-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study held.
- **Last updated:** 2024-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04294875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04294875, "Phase I, FIH, MTD for MPT0B640, Multi-centre, Open-label, Subject With Locally Advanced or Metastatic Solid Malignancies". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04294875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*